Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 9
Submit an article Journal homepage
270
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of exenatide administered before the two largest daily meals of Latin American patients with type 2 diabetes

Adriana Forti Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Brazil
,
Eduardo Garcia Garcia Instituto Nacional de Ciencias Médicas y de Nutrición Salvador Zubirán, Mexico City, Mexico
,
Maria B. Yu Lilly Research Laboratories, Toronto, ON, Canada
,
Maria C. Jimenez Lilly Research Laboratories, Indianapolis, IN, USA
,
Robert G. Brodows Lilly Research Laboratories, Indianapolis, IN, USA
&
Juliana H. Oliveira Lilly Research Laboratories, Indianapolis, IN, USACorrespondence[email protected]
Pages 2437-2447 | Accepted 20 Jun 2008, Published online: 23 Jul 2008

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Xiao-Hui Guo. (2016) The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide. Current Medical Research and Opinion 32:1, pages 61-76.
Read now
Keith C. Ferdinand & Samar A. Nasser. (2015) Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus. Current Medical Research and Opinion 31:5, pages 913-923.
Read now
Richard Pencek, Amy Blickensderfer, Yan Li, Steven C. Brunell & Pamela W. Anderson. (2012) Exenatide Twice Daily: Analysis of Effectiveness and Safety Data Stratified by Age, Sex, Race, Duration of Diabetes, and Body Mass Index. Postgraduate Medicine 124:4, pages 21-32.
Read now
K. Esposito, C. Mosca, C. Brancario, P. Chiodini, A. Ceriello & D. Giugliano. (2011) GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Current Medical Research and Opinion 27:8, pages 1519-1528.
Read now

Articles from other publishers (11)

Qiuhe Ji. (2017) Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists. Clinical Therapeutics 39:6, pages 1244-1264.
Crossref
A Enrique Caballero. (2016) Glp-1 Analogues for the Treatment of Type 2 Diabetes in Latinos/Hispanics. Endocrine Practice 22:12, pages 1459-1461.
Crossref
Silvia Beatriz Gorban de Lapertosa, Gustavo Frechtel, Elise Hardy & Leobardo Sauque-Reyna. (2016) The effects of exenatide twice daily compared to insulin lispro added to basal insulin in Latin American patients with type 2 diabetes: A retrospective analysis of the 4B trial. Diabetes Research and Clinical Practice 122, pages 38-45.
Crossref
Paul L. McCormack. (2014) Exenatide Twice Daily: A Review of Its Use in the Management of Patients with Type 2 Diabetes Mellitus. Drugs 74:3, pages 325-351.
Crossref
Alfonso López Ruiz, María Ángeles Núñez Sánchez, Noelia Victoria García-Talavera Espín, Amparo Meoro Avilés, Cristina del Peso Gilsanz, Ricardo Soriano Sánchez, María Teresa Gallego García, José Soriano Palao, María Dolores Ortuño, Sacramento Tomás Navarro & Collaborative Groups of the Diabetes and Obesity Unit of the Hospital Reina Sofía. (2014) Optimization of Exenatide plus Detemir Treatment for Morbid Obese Patients with Insulin Dependent Diabetes Resistant to Conventional Treatment. Effect of Exenatide on Patients with Mellitus Diabetes Type 2. Pharmacology & Pharmacy 05:04, pages 433-443.
Crossref
Vanita R. Aroda, Robert R. Henry, Jenny Han, Wenying Huang, Mary Beth DeYoung, Tamara Darsow & Byron J. Hoogwerf. (2012) Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review. Clinical Therapeutics 34:6, pages 1247-1258.e22.
Crossref
J. H. Best, K. Lavillotti, M. B. DeYoung & L. P. Garrison. (2011) The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review. Diabetes, Obesity and Metabolism 14:5, pages 387-398.
Crossref
Eugenio Cersosimo & Nicolas Musi. (2011) Improving Treatment in Hispanic/Latino Patients. The American Journal of Medicine 124:10, pages S16-S21.
Crossref
Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak & Edwin E Salpeter. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak & Edwin E Salpeter (posthumous). 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.